Pennant Investors as of June 30, 2024
Portfolio Holdings for Pennant Investors
Pennant Investors holds 45 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Micron Technology (MU) | 14.8 | $57M | 431k | 131.53 | |
| Amazon (AMZN) | 12.1 | $46M | 240k | 193.25 | |
| Antero Res Call Option (AR) | 11.4 | $44M | 1.3M | 32.63 | |
| TransDigm Group Incorporated (TDG) | 10.8 | $41M | 32k | 1277.61 | |
| Echostar Corp Cl A (SATS) | 10.0 | $38M | 2.2M | 17.81 | |
| Microsoft Corporation (MSFT) | 9.3 | $36M | 80k | 446.95 | |
| Alphabet Cap Stk Cl A (GOOGL) | 8.7 | $33M | 183k | 182.15 | |
| Perimeter Solutions Sa Common Stock | 4.7 | $18M | 2.3M | 7.83 | |
| ODP Corp. (ODP) | 4.1 | $16M | 400k | 39.27 | |
| Valmont Industries (VMI) | 2.9 | $11M | 40k | 274.45 | |
| Ge Vernova (GEV) | 2.7 | $10M | 60k | 171.51 | |
| Vertiv Holdings Com Cl A (VRT) | 2.6 | $10M | 115k | 86.57 | |
| Iris Energy Ordinary Shares (IREN) | 1.4 | $5.3M | 470k | 11.29 | |
| Core Scientific (CORZ) | 1.2 | $4.7M | 500k | 9.30 | |
| Arcutis Biotherapeutics (ARQT) | 0.4 | $1.6M | 171k | 9.30 | |
| Nurix Therapeutics (NRIX) | 0.3 | $1.2M | 57k | 20.87 | |
| Novavax Com New (NVAX) | 0.2 | $763k | 60k | 12.66 | |
| Altimmune Com New (ALT) | 0.2 | $730k | 110k | 6.65 | |
| Fibrogen | 0.2 | $686k | 768k | 0.89 | |
| Agios Pharmaceuticals (AGIO) | 0.2 | $651k | 15k | 43.12 | |
| Fate Therapeutics (FATE) | 0.1 | $479k | 146k | 3.28 | |
| Travere Therapeutics (TVTX) | 0.1 | $459k | 56k | 8.22 | |
| Enanta Pharmaceuticals (ENTA) | 0.1 | $455k | 35k | 12.97 | |
| Igm Biosciences (IGMS) | 0.1 | $446k | 65k | 6.87 | |
| Erasca (ERAS) | 0.1 | $392k | 166k | 2.36 | |
| Arcus Biosciences Incorporated (RCUS) | 0.1 | $361k | 24k | 15.23 | |
| 89bio (ETNB) | 0.1 | $356k | 45k | 8.01 | |
| Zymeworks Del (ZYME) | 0.1 | $329k | 39k | 8.51 | |
| Arcturus Therapeutics Hldg I (ARCT) | 0.1 | $319k | 13k | 24.35 | |
| Allogene Therapeutics (ALLO) | 0.1 | $299k | 128k | 2.33 | |
| Coherus Biosciences (CHRS) | 0.1 | $291k | 168k | 1.73 | |
| Relay Therapeutics (RLAY) | 0.1 | $276k | 42k | 6.52 | |
| Replimune Group (REPL) | 0.1 | $275k | 31k | 9.00 | |
| Uniqure Nv SHS (QURE) | 0.1 | $217k | 49k | 4.48 | |
| Seres Therapeutics | 0.1 | $212k | 292k | 0.72 | |
| Compass Therapeutics (CMPX) | 0.1 | $199k | 199k | 1.00 | |
| Sage Therapeutics (SAGE) | 0.0 | $190k | 18k | 10.86 | |
| Getaround (GETR) | 0.0 | $189k | 1.3M | 0.14 | |
| Macrogenics (MGNX) | 0.0 | $186k | 44k | 4.25 | |
| Allakos | 0.0 | $186k | 186k | 1.00 | |
| Allovir (ALVR) | 0.0 | $156k | 216k | 0.72 | |
| Zentalis Pharmaceuticals (ZNTL) | 0.0 | $133k | 32k | 4.09 | |
| Bioxcel Therapeutics | 0.0 | $107k | 84k | 1.28 | |
| Bluebird Bio | 0.0 | $86k | 87k | 0.98 | |
| Grab Holdings *w Exp 99/99/999 (GRABW) | 0.0 | $13k | 80k | 0.16 |
